Reply to Letter to Editor from Juan-Enrique Schwarze and colleagues – Critical appraisal on “Determining the cost-effectiveness of follitropin alfa biosimilar compared to follitropin alfa originator in women undergoing fertility treatment in France”

IF 1.5 Q3 OBSTETRICS & GYNECOLOGY

European Journal of Obstetrics and Gynecology and Reproductive Biology: X Pub Date : 2024-08-02 DOI:10.1016/j.eurox.2024.100331

Matthieu Lehmann, Jean-Luc Pouly, Paul Barrière, Lauren Amy Boland, Samuel George Bean, Julian Jenkins

引用次数: 0

查看原文本刊更多论文

对 Juan-Enrique Schwarze 及其同事致编辑的信的回复--关于 "确定在法国接受生育治疗的妇女中，与促性腺激素 alfa 原研药相比，促性腺激素 alfa 生物仿制药的成本效益 "的批判性评价

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

European Journal of Obstetrics and Gynecology and Reproductive Biology: X Medicine-Obstetrics and Gynecology

CiteScore

2.20

自引率

0.00%

发文量

审稿时长

58 days